Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Phathom Pharmaceuticals Inc (PHAT)

  • Event
  • May 25, 2022, 12:05 UTC
  • 9
  • 1 comments

(19% Negative) PHATHOM PHARMACEUTICALS, INC. (PHAT) Announces Regulatory Update

Comment Full text

Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI)

  • Event
  • May 25, 2022, 11:31 UTC
  • 9
  • 1 comments

(90% Positive) AERIE PHARMACEUTICALS INC (AERI) Provides Update on responsibility for Aerie shares

Comment Full text

Verrica Pharmaceuticals (VRCA)

  • Event
  • May 25, 2022, 11:30 UTC
  • 9
  • 1 comments

(99% Neutral) Verrica Pharmaceuticals Inc. (VRCA) Announces Regulatory Update

Comment Full text

Crinetics Pharmaceuticals Inc (CRNX)

  • Event
  • May 25, 2022, 11:02 UTC
  • 9
  • 1 comments

(75% Positive) Crinetics Pharmaceuticals, Inc. (CRNX) Provides Update on program for Crinetics’ business

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Event
  • May 25, 2022, 10:42 UTC
  • 7
  • 1 comments

(99% Neutral) ADAPTIMMUNE THERAPEUTICS PLC (ADAP) Announces Regulatory Update

Comment Full text

Zentalis Pharmaceuticals (ZNTL)

  • Event
  • May 24, 2022, 21:24 UTC
  • 7
  • 1 comments

(50% Neutral) ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Files Form 8-K

Comment Full text

Athira Pharma Inc (ATHA)

  • Event
  • May 24, 2022, 21:01 UTC
  • 7
  • 1 comments

(99% Neutral) Athira Pharma, Inc. (ATHA) Files Form 8-K

Comment Full text

uniQure NV (QURE)

  • Event
  • May 24, 2022, 20:45 UTC
  • 7
  • 1 comments

(85% Positive) uniQure N.V. (QURE) Provides Update on adults for hemophilia

Comment Full text

Epizyme Inc Ipsen (the company became a subdivision of the company IPSEN (Euronext: IPN; ADR: IPSEY)) (EPZM)

  • Event
  • May 24, 2022, 20:38 UTC
  • 7
  • 1 comments

(99% Neutral) EPIZYME, INC. (EPZM) Files Form 8-K

Comment Full text

Halozyme Therapeutics Inc (HALO)

  • Event
  • May 24, 2022, 20:16 UTC
  • 7
  • 1 comments

(70% Positive) HALOZYME THERAPEUTICS, INC. (HALO) Announces Business Combination

Comment Full text
  • Previous
  • 206
  • 207
  • 208
  • 209
  • 210
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2261)
  • SEC News(189437)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124583)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin